ErbB4 expression in squamous cell carcinoma of the head and neck
Autor: | Sylvia Marmor, Avi Khafif, Rami Ben-Yosef, Alex Starr, Diana Matceyevsky, Akiva Vexler |
---|---|
Rok vydání: | 2006 |
Předmět: |
Larynx
Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Targeted therapy Radiation therapy stomatognathic diseases medicine.anatomical_structure Concomitant Internal medicine Cohort medicine Immunohistochemistry Pharmacology (medical) Stage (cooking) business |
Zdroj: | Targeted Oncology. 1:181-185 |
ISSN: | 1776-260X 1776-2596 |
Popis: | This study set out to delineate ErbB4 overexpression and its impact on prognosis in squamous cell carcinoma (SCC) of head and neck (H&N) origin. Thirty-six of the 47 evaluated SCC of H&N origin came from the larynx, oropharynx, or oral cavity. Twenty-four patients had stage III–IV, 17 had stage I–II, and 6 had recurrent disease. Immunohistochemical stains were performed on paraffin sections using the avidin–biotin–peroxidase method. Forty-five patients received radiation therapy, 24 primary treatment and 21 postoperatively. Nineteen patients with advanced stage disease received concomitant chemotherapy. ErbB4 was highly stained in 24/47 (51%) patients and weakly stained in another 13/47 (28%) patients. Age, gender, site, stage, and treatment approaches similarly distributed between the groups. Overall survival (OS) and disease-free survival (DFS) were similar in ErbB4-positive and ErbB4-negative groups. In conclusion, although ErbB4 is not a prognostic parameter for OS and DFS in H&N SCC, it is highly overexpressed. The high overexpression rate may lead to initiation of anti-ErbB4 targeted therapy in this cohort of patients. |
Databáze: | OpenAIRE |
Externí odkaz: |